Gyrodyne, LLC (NASDAQ:GYRO – Get Rating)'s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $9.11 and traded as low as $8.03. Gyrodyne shares last traded at $8.03, with a volume of 100 shares trading hands.
Gyrodyne Stock Down 5.3 %
The company has a fifty day moving average price of $8.53 and a two-hundred day moving average price of $9.11. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.43.
Get Gyrodyne alerts:Institutional Investors Weigh In On Gyrodyne
An institutional investor recently raised its position in Gyrodyne stock. Gabelli Funds LLC lifted its stake in shares of Gyrodyne, LLC (NASDAQ:GYRO – Get Rating) by 1.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 144,104 shares of the real estate investment trust's stock after purchasing an additional 1,547 shares during the period. Gabelli Funds LLC owned approximately 9.74% of Gyrodyne worth $2,019,000 at the end of the most recent quarter. 41.39% of the stock is currently owned by hedge funds and other institutional investors.
Gyrodyne Company Profile
(Get Rating)
Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.
See Also
- Get a free copy of the StockNews.com research report on Gyrodyne (GYRO)
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.